... a case event and had the same type of index ACS (unstableangina or myocardialinfarction) as that of the respective case patients ... daily, or matching placebo, beginning 4 to 12 weeks after ACS AbstractText: Death due to coronary heart disease, a major nonfatal coronary event (myocardialinfarction, hospitalization for unstableangina, or resuscitated cardiac arrest), or fatal or nonfatal ischemic stroke ...
... colchicine therapy plus optimal medical therapy (OMT) in patients post-acutecoronarysyndrome (ACS), as assessed by coronary computed tomography angiography (coronary CTA) AbstractText ... postulated to have beneficial anti-inflammatory effects in patients with ACS, translating into reduction in future adverse cardiovascular events... this prospective nonrandomized observational study of 80 patients with recent ACS ( <1 month), patients received either 0.5 mg/day colchicine plus ... Keyword: acutecoronarysyndrome.
A cardiactroponin concentration of less than 5 ng/L identifies patients at ... threshold is uncertain AbstractText: To evaluate the performance of a cardiactroponin I threshold of 5 ng/L at presentation as a risk stratification tool in patients with suspected acutecoronarysyndrome AbstractText: Systematic search of MEDLINE, EMBASE, Cochrane, and Web of ...
... on coronary plaque characteristics and ischemic outcomes in patients with acutecoronarysyndromes (ACS) AbstractText: Pre-DM (i.e., the early stages of glucometabolic disturbance) is common among patients with ACS, but the extent to which pre-DM influences coronary plaque ... Study Predictors of Events in Coronary Tree) study, patients with ACS underwent quantitative coronary angiography, grayscale intravascular ultrasound, and radiofrequency intravascular ...
Safety end points were missed acutecoronarysyndrome (ACS) and cumulative radiation exposure during the index visit and follow-up period AbstractText: Of ... Lack of testing was associated with a lower rate of diagnosis of ACS (0% vs 9%; P < .001) and less coronary angiography and percutaneous coronary intervention (PCI ...
Men's Health (5), Cardiovascular Diseases (1) Acute Coronary Syndrome (1), Myocardial Ischemia (1), more mentions
... factors associated with transradial access (TRA) in ST-segment elevation myocardialinfarction (STEMI) percutaneous coronary intervention (PCI), the variation in use across operators ... relationship with mortality and bleeding AbstractText: TRA for PCI in STEMI is underutilized... use as well as determine the variation in TRA for STEMI PCI from 2009 to 2015.
... primary prevention in a cohort of adults who experienced a first-time myocardialinfarction (MI) at a young age AbstractText: The YOUNG-MI registry is a ... was 45 years, there were 294 (20%) women, and 846 (57%) had STEMI... highlight the need for better risk assessment tools among young adults Keyword: myocardialinfarction.
Subgroup analyses were conducted according to surgical technique (i.e., on vs off pump) and clinical presentation (acutecoronarysyndrome vs no acutecoronarysyndrome... There was no difference in myocardialinfarction, stroke, or major bleeding between the 2 groups. In conclusion, DAPT appears to be associated with a reduction in graft occlusion, major adverse cardiac events, and all-cause ...
... represents standard care for treating patients with ST-segment elevation myocardialinfarction (STEMI... minutes and 1 hour after LD administration in patients with STEMI AbstractText: A randomized clinical trial was conducted in adults aged ... Analyses were intention-to-treat AbstractText: Fifty patients with STEMI were randomized to either chewing an LD of ticagrelor, 180 ...
Angina management after acute myocardialinfarction (MI) treated with percutaneous coronary intervention (PCI) is unknown AbstractText: TRANSLATE-ACS (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After AcuteCoronarySyndrome) was a longitudinal study of MI patients treated with percutaneous coronary intervention ... Keyword: myocardialinfarction.
Trending in Altmetric
This article is in the top 10% of similar research outputs scored by Altmetric,
a service which tracks the online attention articles have received.
McMaster PLUS Selected
This article has been identified as especially clinically relevant or newsworthy by at least 3
practicing clinicians and of high scientific quality by expert researchers
as a part of the McMaster PLUS article rating service.
... years or older; had stable angina, silent ischaemia, or an acutecoronarysyndrome; and had at least one coronary artery with a stenosis ... and cerebrovascular events (ie, a composite of all-cause mortality, myocardialinfarction, stroke, or ischaemia-driven target lesion revascularisation) between groups at ... DAPT with respect to the occurrence of all-cause mortality, myocardialinfarction, stroke, and ischaemia-driven target lesion revascularisation.
Senior Health (4), Cardiovascular Diseases (4) Myocardial Infarction (2), Thrombosis (1), Allergy (1), more mentions
Abstract: Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the treatment of choice for the prevention of atherothrombotic events in patients with acutecoronarysyndromes and for those undergoing percutaneous coronary interventions. The availability of different oral P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) has enabled physicians to contemplate switching among therapies because of specific clinical scenarios.
... positive predictive value, and negative predictive value were 93.0%, 91.4%, 94.4%, 93.3%, and 92.7%, respectively. These results were similar in patients with acutecoronarysyndrome and stable angina AbstractText: Pd/Pa was analyzable in a significantly higher number of patients than iFR. Pd/Pa showed excellent agreement with iFR, suggesting that it could be applied clinically in a similar fashion.
The primary end point was a composite of cardiovascular death, myocardialinfarction, stroke, hospital admission for unstableangina, or coronary revascularization. The key secondary end point was a composite of cardiovascular death, myocardialinfarction, or stroke... hundred forty-two patients (13.2%) had PAD (1505 with no prior myocardialinfarction or stroke.
... patients with coronary artery disease had to have had a myocardialinfarction in the past 20 years, multi-vessel coronary artery disease, history of stable or unstableangina, previous multi-vessel percutaneous coronary intervention, or previous multi-vessel ... primary outcome of the COMPASS trial was the occurrence of myocardialinfarction, stroke, or cardiovascular death.
Major adverse cardiovascular events (defined as myocardialinfarction, stroke, or death) within 12 months of PCI were compared between patients with a loss ... Similar results were observed among 1,210 patients with acutecoronarysyndromes at the time of PCI (adjusted hazard ratio: 2.87; 95% confidence interval: 1.35 to 6.09 ...
Cardiovascular Diseases (1) Myocardial Infarction (1), more mentions
... the success or failure of the WA AbstractText: Patients (n = 13) aged 49 ± 18 years, who received VA-ECMO for the treatment of refractory CS due to pulmonary embolism (n = 5), post cardiotomy (n = 3), acutecoronarysyndrome (n = 2), myocarditis (n = 2) and drug intoxication (n = 1), were included.
The American College of Surgeons (ACS) NSQIP Geriatric Surgery Pilot collected risk factors and outcomes in ... mobility aid use, functional decline, and pressure ulcers) AbstractText: Using ACS NSQIP Geriatric Surgery Pilot data (January 2014 to December 2016 ... older adults who underwent operations at 31 hospitals in the ACS NSQIP Geriatric Surgery Pilot.